SYMPOSIA PAPER Published: 01 January 1996
STP16094S

A 3-Year Prospective Study of Serum Titanium Levels in Patients with Primary Total Hip Replacements

Source

Serum titanium concentration was measured in subjects undergoing primary total hip replacement (THR) using a prospective, controlled, longitudinal study design. One group of subjects underwent “hybrid” THR utilizing a commercially pure titanium (cp Ti) acetabular component inserted without bone cement and a modular cobalt-base alloy femoral component inserted with bone cement. A second group underwent cementless primary THR utilizing a titanium-6% aluminum-4% vanadium modular femoral component and a cp Ti acetabular component. A third group of subjects consisted of contemporaneous age and sex matched controls without implants or systemic disease. Serum titanium levels are elevated at all intervals up to 3 years postoperative in patients with cementless titanium alloy THR with respect to the baseline preoperative concentration and with respect to controls without implants. The “hybrid” THRs also demonstrate serum titanium elevations with respect to controls. At this juncture, we have observed no correlation between serum titanium levels and clinical function, nor have we identified any toxic effects.

Author Information

Jacobs, JJ
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il
Skipor, AK
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il
Black, J
IMN Biomaterials, King of Prussia, PA
Patterson, LM
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il
Paprosky, WP
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il
Galante, JO
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il
Price: $25.00
Contact Sales
Related
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center
Details
Developed by Committee: F04
Pages: 400–408
DOI: 10.1520/STP16094S
ISBN-EB: 978-0-8031-5330-1
ISBN-13: 978-0-8031-2010-5